Logo image of SGHT

SIGHT SCIENCES INC (SGHT) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:SGHT - US82657M1053 - Common Stock

8.39 USD
+0.29 (+3.58%)
Last: 11/26/2025, 8:03:20 PM
8.8833 USD
+0.49 (+5.88%)
After Hours: 11/26/2025, 8:03:20 PM
Fundamental Rating

3

Taking everything into account, SGHT scores 3 out of 10 in our fundamental rating. SGHT was compared to 188 industry peers in the Health Care Equipment & Supplies industry. The financial health of SGHT is average, but there are quite some concerns on its profitability. SGHT is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year SGHT has reported negative net income.
In the past year SGHT has reported a negative cash flow from operations.
In the past 5 years SGHT always reported negative net income.
SGHT had a negative operating cash flow in each of the past 5 years.
SGHT Yearly Net Income VS EBIT VS OCF VS FCFSGHT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M

1.2 Ratios

The Return On Assets of SGHT (-39.66%) is worse than 62.77% of its industry peers.
SGHT's Return On Equity of -71.72% is in line compared to the rest of the industry. SGHT outperforms 42.02% of its industry peers.
Industry RankSector Rank
ROA -39.66%
ROE -71.72%
ROIC N/A
ROA(3y)-36.62%
ROA(5y)-36%
ROE(3y)-52.97%
ROE(5y)-61.55%
ROIC(3y)N/A
ROIC(5y)N/A
SGHT Yearly ROA, ROE, ROICSGHT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150 -200 -250

1.3 Margins

SGHT has a Gross Margin of 86.83%. This is amongst the best in the industry. SGHT outperforms 95.74% of its industry peers.
SGHT's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for SGHT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 86.83%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.23%
GM growth 5Y3.51%
SGHT Yearly Profit, Operating, Gross MarginsSGHT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

More info and screens

4

2. Health

2.1 Basic Checks

SGHT does not have a ROIC to compare to the WACC, probably because it is not profitable.
SGHT has more shares outstanding than it did 1 year ago.
SGHT has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, SGHT has a worse debt to assets ratio.
SGHT Yearly Shares OutstandingSGHT Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
SGHT Yearly Total Debt VS Total AssetsSGHT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

Based on the Altman-Z score of 0.92, we must say that SGHT is in the distress zone and has some risk of bankruptcy.
SGHT has a Altman-Z score (0.92) which is in line with its industry peers.
A Debt/Equity ratio of 0.62 indicates that SGHT is somewhat dependend on debt financing.
SGHT's Debt to Equity ratio of 0.62 is on the low side compared to the rest of the industry. SGHT is outperformed by 64.89% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF N/A
Altman-Z 0.92
ROIC/WACCN/A
WACC8.68%
SGHT Yearly LT Debt VS Equity VS FCFSGHT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

SGHT has a Current Ratio of 9.60. This indicates that SGHT is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 9.60, SGHT belongs to the best of the industry, outperforming 92.02% of the companies in the same industry.
A Quick Ratio of 8.93 indicates that SGHT has no problem at all paying its short term obligations.
SGHT's Quick ratio of 8.93 is amongst the best of the industry. SGHT outperforms 92.55% of its industry peers.
Industry RankSector Rank
Current Ratio 9.6
Quick Ratio 8.93
SGHT Yearly Current Assets VS Current LiabilitesSGHT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

4

3. Growth

3.1 Past

SGHT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 11.76%, which is quite good.
The Revenue has decreased by -4.39% in the past year.
Measured over the past years, SGHT shows a very strong growth in Revenue. The Revenue has been growing by 27.88% on average per year.
EPS 1Y (TTM)11.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%27.27%
Revenue 1Y (TTM)-4.39%
Revenue growth 3Y17.72%
Revenue growth 5Y27.88%
Sales Q2Q%-1.25%

3.2 Future

SGHT is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.89% yearly.
Based on estimates for the next years, SGHT will show a quite strong growth in Revenue. The Revenue will grow by 8.86% on average per year.
EPS Next Y-0.23%
EPS Next 2Y11.5%
EPS Next 3Y10.85%
EPS Next 5Y5.89%
Revenue Next Year-7.86%
Revenue Next 2Y1.6%
Revenue Next 3Y5.96%
Revenue Next 5Y8.86%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SGHT Yearly Revenue VS EstimatesSGHT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 20M 40M 60M 80M 100M
SGHT Yearly EPS VS EstimatesSGHT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 -0.5 -1 -1.5 -2

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

SGHT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SGHT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SGHT Price Earnings VS Forward Price EarningsSGHT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SGHT Per share dataSGHT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.5%
EPS Next 3Y10.85%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SGHT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SIGHT SCIENCES INC

NASDAQ:SGHT (11/26/2025, 8:03:20 PM)

After market: 8.8833 +0.49 (+5.88%)

8.39

+0.29 (+3.58%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-06 2025-11-06/amc
Earnings (Next)03-03 2026-03-03/amc
Inst Owners50.34%
Inst Owner Change-1.62%
Ins Owners19.31%
Ins Owner Change2.46%
Market Cap439.38M
Revenue(TTM)76.05M
Net Income(TTM)-46.11M
Analysts76.92
Price Target6.2 (-26.1%)
Short Float %2.33%
Short Ratio5.05
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)26.11%
Min EPS beat(2)14.4%
Max EPS beat(2)37.82%
EPS beat(4)3
Avg EPS beat(4)11.04%
Min EPS beat(4)-10.81%
Max EPS beat(4)37.82%
EPS beat(8)5
Avg EPS beat(8)9.01%
EPS beat(12)9
Avg EPS beat(12)11.07%
EPS beat(16)11
Avg EPS beat(16)7.09%
Revenue beat(2)2
Avg Revenue beat(2)7.73%
Min Revenue beat(2)5.48%
Max Revenue beat(2)9.98%
Revenue beat(4)3
Avg Revenue beat(4)3.47%
Min Revenue beat(4)-5.54%
Max Revenue beat(4)9.98%
Revenue beat(8)4
Avg Revenue beat(8)1.09%
Revenue beat(12)5
Avg Revenue beat(12)-0.07%
Revenue beat(16)9
Avg Revenue beat(16)1.15%
PT rev (1m)37.73%
PT rev (3m)42.58%
EPS NQ rev (1m)29.1%
EPS NQ rev (3m)38.16%
EPS NY rev (1m)0%
EPS NY rev (3m)1.14%
Revenue NQ rev (1m)6.13%
Revenue NQ rev (3m)6.13%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.47%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.78
P/FCF N/A
P/OCF N/A
P/B 6.83
P/tB 6.83
EV/EBITDA N/A
EPS(TTM)-0.9
EYN/A
EPS(NY)-0.78
Fwd EYN/A
FCF(TTM)-0.61
FCFYN/A
OCF(TTM)-0.6
OCFYN/A
SpS1.45
BVpS1.23
TBVpS1.23
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -39.66%
ROE -71.72%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 86.83%
FCFM N/A
ROA(3y)-36.62%
ROA(5y)-36%
ROE(3y)-52.97%
ROE(5y)-61.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.23%
GM growth 5Y3.51%
F-Score3
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 93.15%
Cap/Sales 0.68%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 9.6
Quick Ratio 8.93
Altman-Z 0.92
F-Score3
WACC8.68%
ROIC/WACCN/A
Cap/Depr(3y)106.51%
Cap/Depr(5y)124.16%
Cap/Sales(3y)0.94%
Cap/Sales(5y)1.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)11.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%27.27%
EPS Next Y-0.23%
EPS Next 2Y11.5%
EPS Next 3Y10.85%
EPS Next 5Y5.89%
Revenue 1Y (TTM)-4.39%
Revenue growth 3Y17.72%
Revenue growth 5Y27.88%
Sales Q2Q%-1.25%
Revenue Next Year-7.86%
Revenue Next 2Y1.6%
Revenue Next 3Y5.96%
Revenue Next 5Y8.86%
EBIT growth 1Y9.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year14.09%
EBIT Next 3Y12.18%
EBIT Next 5YN/A
FCF growth 1Y44.01%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y44.27%
OCF growth 3YN/A
OCF growth 5YN/A

SIGHT SCIENCES INC / SGHT FAQ

What is the fundamental rating for SGHT stock?

ChartMill assigns a fundamental rating of 3 / 10 to SGHT.


What is the valuation status for SGHT stock?

ChartMill assigns a valuation rating of 0 / 10 to SIGHT SCIENCES INC (SGHT). This can be considered as Overvalued.


Can you provide the profitability details for SIGHT SCIENCES INC?

SIGHT SCIENCES INC (SGHT) has a profitability rating of 2 / 10.


What is the financial health of SIGHT SCIENCES INC (SGHT) stock?

The financial health rating of SIGHT SCIENCES INC (SGHT) is 4 / 10.